|
Invited Speakers:
|
|
Suzette Kox, Senior Director Scientifi c Affairs, European Generic Medicines Association (EGA), Belgium Julie Seawall, Executive Director, Business Development, Merck BioVentures, USA Dr Arthur Alston, Regulatory Affairs, Special Projects, Roche, Switzerland Dr Subir Basak, Chief Executive Officer, Celestial Biologicals Limited, Chief Commercial Officer, Intas Biopharmaceuticals Ltd, India Dr Stanley Hong, Senior Vice President, Research & Development, Celltrion, South Korea Michael Corbo, Vice President & Chief Development Offi cer, Bio-enhancement Development Unit, Pfi zer, USA
|
|